Wells Fargo & Company 10x Genomics, Inc. Transaction History

Wells Fargo & Company

  • $433 Billion
  • Q4 2024

A detailed history of Wells Fargo & Company transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 1,393 shares of TXG stock, worth $15,114. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,393
Previous 11,928 88.32%
Holding current value
$15,114
Previous $269,000 92.57%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 12, 2025
SELL
$13.18 - $21.31 $138,851 - $224,500
-10,535 Reduced 88.32%
1,393 $20,000
Q3 2024

Nov 13, 2024
BUY
$15.71 - $23.49 $34,499 - $51,584
2,196 Added 22.56%
11,928 $269,000
Q2 2024

Aug 13, 2024
SELL
$19.45 - $37.37 $144,377 - $277,397
-7,423 Reduced 43.27%
9,732 $189,000
Q1 2024

May 10, 2024
SELL
$36.08 - $54.3 $343,192 - $516,501
-9,512 Reduced 35.67%
17,155 $643,000
Q4 2023

Feb 09, 2024
SELL
$34.32 - $57.55 $411,462 - $689,966
-11,989 Reduced 31.01%
26,667 $1.49 Million
Q3 2023

Nov 13, 2023
SELL
$40.86 - $62.98 $262,688 - $404,898
-6,429 Reduced 14.26%
38,656 $1.59 Million
Q2 2023

Aug 15, 2023
BUY
$50.96 - $58.72 $378,021 - $435,584
7,418 Added 19.69%
45,085 $2.52 Million
Q1 2023

May 12, 2023
SELL
$35.33 - $55.79 $1.18 Million - $1.86 Million
-33,414 Reduced 47.01%
37,667 $2.1 Million
Q4 2022

Feb 13, 2023
SELL
$24.4 - $41.3 $453,132 - $766,982
-18,571 Reduced 20.71%
71,081 $2.59 Million
Q3 2022

Nov 14, 2022
SELL
$28.48 - $52.59 $1.12 Million - $2.07 Million
-39,390 Reduced 30.52%
89,652 $2.55 Million
Q2 2022

Aug 12, 2022
SELL
$36.95 - $82.41 $4.38 Million - $9.78 Million
-118,646 Reduced 47.9%
129,042 $5.84 Million
Q1 2022

May 16, 2022
BUY
$55.7 - $145.79 $3.02 Million - $7.9 Million
54,217 Added 28.02%
247,688 $18.8 Million
Q4 2021

Feb 14, 2022
SELL
$135.05 - $182.59 $80.8 Million - $109 Million
-598,229 Reduced 75.56%
193,471 $28.8 Million
Q3 2021

Nov 15, 2021
BUY
$145.58 - $192.14 $3.46 Million - $4.56 Million
23,753 Added 3.09%
791,700 $115 Million
Q2 2021

Aug 16, 2021
BUY
$134.22 - $202.37 $1.15 Million - $1.74 Million
8,574 Added 1.13%
767,947 $150 Million
Q1 2021

May 13, 2021
BUY
$140.25 - $196.86 $99.1 Million - $139 Million
706,619 Added 1339.46%
759,373 $137 Million
Q4 2020

Feb 09, 2021
BUY
$126.47 - $163.7 $2.44 Million - $3.16 Million
19,293 Added 57.66%
52,754 $7.47 Million
Q3 2020

Nov 05, 2020
SELL
$87.44 - $125.0 $20.1 Million - $28.8 Million
-230,034 Reduced 87.3%
33,461 $4.17 Million
Q2 2020

Aug 13, 2020
SELL
$58.39 - $89.31 $29.9 Million - $45.7 Million
-511,359 Reduced 65.99%
263,495 $23.5 Million
Q1 2020

May 14, 2020
BUY
$51.57 - $106.62 $40 Million - $82.6 Million
774,854 New
774,854 $48.3 Million

Others Institutions Holding TXG

# of Institutions
302
Shares Held
96.5M
Call Options Held
76.4K
Put Options Held
132K
View Full List

About 10x Genomics, Inc.

TXG Quotes by TradingView
  • Ticker TXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 95,046,400
  • Market Cap $1.03B
  • Description
  • 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...
More about TXG
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email